PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8267880-4	1993	The two models allowed for CD spectroscopic titrations of zinc and cobalt insulin with phenol and m-cresol to be assessed in terms of structural reorganisation and ligand binding, and for the respective standard free energy differences to be calculated.	Cobalt	67-73	insulin	Homo sapiens	74-81	
8267880-7	1993	For both zinc- and cobalt-insulin, the delta G degrees for phenol and m-cresol binding is about -18 kJ/mol.	Cobalt	19-25	insulin	Homo sapiens	26-33	
34993787-0	2022	Dose-response relationships between urinary cobalt concentrations and obesity, insulin resistance, and metabolic-related disorders in the general population.	Cobalt	44-50	insulin	Homo sapiens	79-86	
33773581-0	2021	Sex differences in the link between blood cobalt concentrations and insulin resistance in adults without diabetes.	Cobalt	42-48	insulin	Homo sapiens	68-75	
33773581-1	2021	BACKGROUND: Little is known about the effects of environmental cobalt exposure on insulin resistance (IR) in the general adult population.	Cobalt	63-69	insulin	Homo sapiens	82-89	
33773581-5	2021	Regression coefficients and 95% confidence intervals (CIs) of blood cobalt concentrations in association with fasting glucose, insulin and homeostatic model assessment of insulin resistance (HOMA-IR) were estimated using multivariate linear regression after adjusting for age, sex, ethnicity, alcohol consumption, body mass index, education level, and household income.	Cobalt	68-74	insulin	Homo sapiens	127-134	
33773581-5	2021	Regression coefficients and 95% confidence intervals (CIs) of blood cobalt concentrations in association with fasting glucose, insulin and homeostatic model assessment of insulin resistance (HOMA-IR) were estimated using multivariate linear regression after adjusting for age, sex, ethnicity, alcohol consumption, body mass index, education level, and household income.	Cobalt	68-74	insulin	Homo sapiens	171-178	
34993787-2	2022	However, the relationships between cobalt exposure and obesity, insulin resistance, and metabolic-related disorders are rarely studied in epidemiological studies.	Cobalt	35-41	insulin	Homo sapiens	64-71	
34993787-3	2022	This study aimed to explore the dose-response relationships between urinary cobalt concentrations and obesity, insulin resistance, and metabolic-related disorders.	Cobalt	76-82	insulin	Homo sapiens	111-118	
34993787-8	2022	In conclusion, the prevalence of obesity, insulin resistance, metabolic syndrome, elevated waist circumference, elevated triglycerides, and reduced HDL-C progressively increased with increasing urinary cobalt concentrations.	Cobalt	202-208	insulin	Homo sapiens	42-49	
2423368-4	1986	Substitution of Ba2+ for Ca2+ triggered a practically normal release of insulin that was inhibited by blockers of Ca2+ channels (cobalt or D 600) and abolished by low temperature.	Cobalt	129-135	insulin	Homo sapiens	72-79	
2695115-0	1989	Cobalt probing of structural alternatives for insulin in solution.	Cobalt	0-6	insulin	Homo sapiens	46-53	
6065219-0	1967	[Effect of insulin and other hormones on penetration of cobalt ion and vitamin B 12 into liver cells].	Cobalt	56-62	insulin	Homo sapiens	11-18